Show simple item record

Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance

dc.contributor.authorStagg, HRen_US
dc.contributor.authorBothamley, GHen_US
dc.contributor.authorDavidson, JAen_US
dc.contributor.authorKunst, Hen_US
dc.contributor.authorLalor, MKen_US
dc.contributor.authorLipman, MCen_US
dc.contributor.authorLoutet, MGen_US
dc.contributor.authorLozewicz, Sen_US
dc.contributor.authorMohiyuddin, Ten_US
dc.contributor.authorAbbara, Aen_US
dc.contributor.authorAlexander, Een_US
dc.contributor.authorBooth, Hen_US
dc.contributor.authorCreer, DDen_US
dc.contributor.authorHarris, RJen_US
dc.contributor.authorKon, OMen_US
dc.contributor.authorLoebinger, MRen_US
dc.contributor.authorMcHugh, TDen_US
dc.contributor.authorMilburn, HJen_US
dc.contributor.authorPalchaudhuri, Pen_US
dc.contributor.authorPhillips, PPJen_US
dc.contributor.authorSchmok, Een_US
dc.contributor.authorTaylor, Len_US
dc.contributor.authorAbubakar, Ien_US
dc.contributor.authorBaker, LVen_US
dc.contributor.authorBarrett, JCen_US
dc.contributor.authorBurgess, Hen_US
dc.contributor.authorCosgrove, Cen_US
dc.contributor.authorDunleavy, Aen_US
dc.contributor.authorFrancis, Men_US
dc.contributor.authorGupta, Uen_US
dc.contributor.authorHamid, Sen_US
dc.contributor.authorHaselden, BMen_US
dc.contributor.authorHolden, Een_US
dc.contributor.authorKahr, Ven_US
dc.contributor.authorLynn, Wen_US
dc.contributor.authorPerrin, FMen_US
dc.contributor.authorRahman, Aen_US
dc.contributor.authorSoobratty, MRen_US
dc.contributor.authorGrp, LINH-RTBSen_US
dc.date.accessioned2020-01-07T15:27:43Z
dc.date.available2019-07-01en_US
dc.date.issued2019-10-01en_US
dc.identifier.issn0903-1936en_US
dc.identifier.otherARTN 1900982en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/62250
dc.language.isoenen_US
dc.relation.ispartofEUROPEAN RESPIRATORY JOURNALen_US
dc.rightsCreative Commons Attribution Non-Commercial Licence 4.0
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.titleFluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidanceen_US
dc.typeArticle
dc.rights.holder©ERS 2019
dc.identifier.doi10.1183/13993003.00982-2019en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000489941300008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue4en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume54en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Name:
Kunst_Fluoroquinolones and ...
Size:
999.6Kb
Format:
application/
Description:
Accepted version
View/Open

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution Non-Commercial Licence 4.0
Except where otherwise noted, this item's license is described as Creative Commons Attribution Non-Commercial Licence 4.0